Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891651673> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2891651673 abstract "4558 Background: The optimal management of progressive brain mets in pts with GCT remains unsettled. Treatment options include chemotherapy, stereotactic or whole brain radiation (XRT), surgery, or a combination thereof. Global germ cell cancer group analysis suggested multimodality therapy improves survival probabilities in pts with brain mets at relapse (JCO.2016;1;34(4):345-51). We report our experience on managing 25 consecutive pts with relapsed GCT and progressive brain mets undergoing HDCT with PBSCT at Indiana University from 2006-2016. Methods: All pts received HDCT consisting of carboplatin 700 mg/m2 days 1-3 and etoposide 750 mg/m2 i.v. days 1-3 followed by PBSCT on day 5 for upto 2 cycles. Pts were treated with craniotomy, XRT, chemotherapy alone, or a combination of modalities. Patient and disease characteristics, management of brain mets, and outcomes were measured. Platelet transfusions were given to maintain platelet counts > 30,000 and goal of > 50,000 in those with signs of hemorrhage. Results: Patient characteristics and outcomes are summarized in Table 1. Median age was 27.7 years (range, 16-48). All pts had progressive brain mets at time of starting HDCT. AFP ranged 1.6 to 1130, hCG 0.5 to 25601. At median follow-up of 24.8 months (range 2.5 to 118.5 months), 11 pts (44%) were alive with NED, 2 pts were alive with relapsed disease, and 12 pts died of disease progression. 17/18 patients developed progressive CNS mets despite radiation and/or craniotomy and of those, 8 are alive with NED. Toxicity was as previously published with this regimen (N Engl J Med 2007;357:340-8). Conclusions: Patients with relapsed GCT with progressing brain mets, including those with prior locoregional therapy, are curable with HDCT. [Table: see text]" @default.
- W2891651673 created "2018-09-27" @default.
- W2891651673 creator A5013478042 @default.
- W2891651673 creator A5032493706 @default.
- W2891651673 creator A5047486042 @default.
- W2891651673 creator A5048660181 @default.
- W2891651673 creator A5053079426 @default.
- W2891651673 creator A5074428655 @default.
- W2891651673 date "2017-05-20" @default.
- W2891651673 modified "2023-09-26" @default.
- W2891651673 title "High-dose chemotherapy (HDCT) plus peripheral-blood stem-cell transplant (PBSCT) for patients (pts) with relapsed germ-cell tumors (GCT) and active brain metastases (mets)." @default.
- W2891651673 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.4558" @default.
- W2891651673 hasPublicationYear "2017" @default.
- W2891651673 type Work @default.
- W2891651673 sameAs 2891651673 @default.
- W2891651673 citedByCount "3" @default.
- W2891651673 countsByYear W28916516732017 @default.
- W2891651673 countsByYear W28916516732018 @default.
- W2891651673 countsByYear W28916516732019 @default.
- W2891651673 crossrefType "journal-article" @default.
- W2891651673 hasAuthorship W2891651673A5013478042 @default.
- W2891651673 hasAuthorship W2891651673A5032493706 @default.
- W2891651673 hasAuthorship W2891651673A5047486042 @default.
- W2891651673 hasAuthorship W2891651673A5048660181 @default.
- W2891651673 hasAuthorship W2891651673A5053079426 @default.
- W2891651673 hasAuthorship W2891651673A5074428655 @default.
- W2891651673 hasConcept C126322002 @default.
- W2891651673 hasConcept C143998085 @default.
- W2891651673 hasConcept C2776694085 @default.
- W2891651673 hasConcept C2776938808 @default.
- W2891651673 hasConcept C28328180 @default.
- W2891651673 hasConcept C3017910909 @default.
- W2891651673 hasConcept C54355233 @default.
- W2891651673 hasConcept C71924100 @default.
- W2891651673 hasConcept C86803240 @default.
- W2891651673 hasConceptScore W2891651673C126322002 @default.
- W2891651673 hasConceptScore W2891651673C143998085 @default.
- W2891651673 hasConceptScore W2891651673C2776694085 @default.
- W2891651673 hasConceptScore W2891651673C2776938808 @default.
- W2891651673 hasConceptScore W2891651673C28328180 @default.
- W2891651673 hasConceptScore W2891651673C3017910909 @default.
- W2891651673 hasConceptScore W2891651673C54355233 @default.
- W2891651673 hasConceptScore W2891651673C71924100 @default.
- W2891651673 hasConceptScore W2891651673C86803240 @default.
- W2891651673 hasLocation W28916516731 @default.
- W2891651673 hasOpenAccess W2891651673 @default.
- W2891651673 hasPrimaryLocation W28916516731 @default.
- W2891651673 hasRelatedWork W1970870660 @default.
- W2891651673 hasRelatedWork W2014477129 @default.
- W2891651673 hasRelatedWork W2125897769 @default.
- W2891651673 hasRelatedWork W2244533749 @default.
- W2891651673 hasRelatedWork W2246967755 @default.
- W2891651673 hasRelatedWork W2247463311 @default.
- W2891651673 hasRelatedWork W2278058249 @default.
- W2891651673 hasRelatedWork W2530160706 @default.
- W2891651673 hasRelatedWork W2887449108 @default.
- W2891651673 hasRelatedWork W2890199421 @default.
- W2891651673 hasRelatedWork W2890317519 @default.
- W2891651673 hasRelatedWork W2921375601 @default.
- W2891651673 hasRelatedWork W2947405135 @default.
- W2891651673 hasRelatedWork W2947933260 @default.
- W2891651673 hasRelatedWork W3028657336 @default.
- W2891651673 hasRelatedWork W3030183368 @default.
- W2891651673 hasRelatedWork W3030610293 @default.
- W2891651673 hasRelatedWork W3167022484 @default.
- W2891651673 hasRelatedWork W3171686542 @default.
- W2891651673 hasRelatedWork W3203391020 @default.
- W2891651673 isParatext "false" @default.
- W2891651673 isRetracted "false" @default.
- W2891651673 magId "2891651673" @default.
- W2891651673 workType "article" @default.